Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study

Jpn J Clin Oncol. 2022 Dec 8:hyac184. doi: 10.1093/jjco/hyac184. Online ahead of print.NO ABSTRACTPMID:36484305 | DOI:10.1093/jjco/hyac184
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Source Type: research